Rznomics joins Lilly Gateway Labs to accelerate RNA therapeutics

Anbogen Therapeutics enters collaborative research agreement with University of Tokyo for ABT-301 evaluation across multiple tumour types

CureGene commences dosing in Phase I trial of CG-0416

Ipsen completes Kartos Therapeutics acquisition, strengthening late-stage oncology pipeline

Nuvation Bio's safusidenib granted FDA Fast Track Designation for IDH1-mutant glioma treatment

Charles River and Medigen collaborate on next-generation enterovirus vaccine development

Annexin Pharmaceuticals receives proposed INN vanexin for ANXV

Pillar Biosciences, LC-SCRUM-Asia and LSI Medience collaborate for liquid biopsy screening in lung cancer

Arcato reports positive Phase 1 trial results for ARC-001 Gel

Vascarta commences NIH phase I clinical study of VAS-101 in sickle cell disease

Amplitude Therapeutics and Lilly collaborate on trans-amplifying RNA vaccine development for infectious diseases

BioArctic and Mesenkia sign research collaboration for glioblastoma antibody project

Tolerance Bio licenses clinical-stage IL-7 therapy from NeoImmuneTech

Merck and Moderna report positive Phase 3 melanoma trial results

Scancell announces UK authorisation for Phase 3 melanoma trial